Nomura Holdings
NMR
9.53
-0.25
-2.56%
Nomura Holdings
US · NMR
#706 by market cap
Listed 1970
9.53
-0.25
-2.56%
Live - 5344 symbols - heartbeat 48s ago
· 2026-10-08 01:31
After-hours
9.53
0.00%
Overnight
9.51
-0.21%
- Market cap
- 27.85B
- P/E (TTM)i
- 11.30
- P/Bi
- 1.15
- EPSi
- 0.75
- Div yieldi
- 3.22%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on NMR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 6 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.7 percentage points.
Institutional ownership
- Held by institutions
- 49.71% -0.67pp
- Institutions
- 535 -6
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund39.90%
Public Company4.01%
Hedge Fund2.27%
Sovereign Wealth Fund1.47%
Private Company1.07%
Government Pension Fund0.74%
Insurance Company0.19%
Individual/Insider0.12%
Other50.18%
Top holders
BlackRock
9.49%
Nomura Asset Management
4.65%
Vanguard Capital Management, LLC
3.86%
Sumitomo Mitsui Trust Asset Management
3.18%
Amova Asset Management
2.15%
Daiwa Asset Management
1.96%
Man Group Plc
1.93%
Sumitomo Mitsui Financial Group, Inc.
1.62%
Norges Bank Investment Management
1.47%
Mitsubishi UFJ Asset Management
1.44%
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 49 buys · 0 sells
| Name | Role | Stake |
|---|---|---|
| Yutaka Nakajima | Representative Executive Officer and Deputy President & Head of Global Markets and Director | 0.02% |
| Kentaro Okuda | President, Group CEO, Representative Executive Officer & Director | 0.02% |
| Koji Nagai | Chairperson | 0.02% |
| Toshiyasu Iiyama | Chief of Staff, Executive Officer & Deputy President | 0.01% |
| Masahiro Goto | Senior MD & Global Head of Investment Banking | 0.01% |
| Shinichi Okada | Senior Managing Director of Banking | 0.01% |
| Takumi Kitamura | Executive Officer, CFO & Investor Relations | 0.00% |
| Hiroyasu Koike | Senior MD & Head of Investment Management | 0.00% |
| Akihito Tobari | Executive Vice President | 0.00% |
| Yoshihiro Namura | Senior MD & Head of Investment Management-Investment Products and Advisory Solutions | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-24 | Hiroyasu Koike | Senior MD & Head of Investment Management | Other Acquisition | +247 | $9.97 |
| 2026-09-24 | Shoji Ogawa | Non-Executive Director | Other Acquisition | +185 | $9.97 |
| 2026-09-24 | Yukiko Ozaki | Senior MD, Chief Human Resources Officer & Chief Health Officer | Other Acquisition | +6 | $9.97 |
| 2026-09-24 | Akihito Tobari | Executive Vice President | Other Acquisition | +61 | $9.97 |
| 2026-09-24 | Akio Hori | Senior Managing Director of Group IT | Other Acquisition | +61 | $9.97 |
| 2026-09-24 | Masahiro Ishizuka | Independent Outside Director | Other Acquisition | +185 | $9.97 |
| 2026-08-24 | Hiroyasu Koike | Senior MD & Head of Investment Management | Other Acquisition | +261 | $9.87 |
| 2026-08-24 | Shoji Ogawa | Non-Executive Director | Other Acquisition | +196 | $9.87 |
| 2026-08-24 | Yukiko Ozaki | Senior MD, Chief Human Resources Officer & Chief Health Officer | Other Acquisition | +6 | $9.87 |
| 2026-08-24 | Akihito Tobari | Executive Vice President | Other Acquisition | +65 | $9.87 |
| 2026-08-24 | Akio Hori | Senior Managing Director of Group IT | Other Acquisition | +65 | $9.87 |
| 2026-08-24 | Masahiro Ishizuka | Independent Outside Director | Other Acquisition | +196 | $9.87 |
| 2026-07-23 | Hiroyasu Koike | Senior MD & Head of Investment Management | Other Acquisition | +245 | $9.83 |
| 2026-07-23 | Shoji Ogawa | Non-Executive Director | Other Acquisition | +183 | $9.83 |
| 2026-07-23 | Yukiko Ozaki | Senior MD, Chief Human Resources Officer & Chief Health Officer | Other Acquisition | +6 | $9.83 |
| 2026-07-23 | Akihito Tobari | Executive Vice President | Other Acquisition | +61 | $9.83 |
| 2026-07-23 | Akio Hori | Senior Managing Director of Group IT | Other Acquisition | +61 | $9.83 |
| 2026-07-23 | Masahiro Ishizuka | Independent Outside Director | Other Acquisition | +183 | $9.83 |
| 2026-06-24 | Koji Nagai | Chairperson | Other Acquisition | 0 | $8.86 |
| 2026-06-24 | Hiroyasu Koike | Senior MD & Head of Investment Management | Other Acquisition | +273 | $8.86 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 01:31:31 · For reference only, not investment advice and not tailored to your situation.